CryoPort, Inc.
20382 Barents Sea Circle
Lake Forest
California
92630
United States
Tel: 949-470-2300
Fax: 949-470-2306
Website: http://www.cryoport.com/
Email: contact@cryoport.com
269 articles about CryoPort, Inc.
-
Cryoport Authorizes Share Repurchase Program and Presenting at Upcoming Investor Conferences
10/9/2019
Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport"), the world's leading temperature-controlled logistics solutions company dedicated to the life sciences industry, today announced its Board of Directors has unanimously authorized a share repurchase program, under which Cryoport may repurchase up to $15 million of its outstanding common stock.
-
Cryoport Introduces Cell & Gene Industry's First Dedicated Shipper for Advanced Therapies
9/18/2019
Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport"), the world's leading temperature-controlled logistics solutions company dedicated to the life sciences industry, today announced the launch of its Advanced Therapy Shipper™ product line for the regenerative medicine market.
-
Cryoport Revenue Grows 83% for Second Quarter 2019
8/8/2019
Cryoport, Inc., the world's leading temperature-controlled logistics company dedicated to the life sciences industry, announced financial results for the three and six-month periods ended June 30, 2019.
-
Cryoport to Report Second Quarter 2019 Financial Results on August 8th, 2019
7/25/2019
Company will report financial results for the second quarter ended June 30, 2019 on Thursday, August 8, 2019 after U.S. markets close.
-
Cryoport and EVERSANA Form Strategic Alliance to Accelerate Regenerative Medicine Supply Chain
7/11/2019
Integrated end-to-end patient and supply chain management platform to support cell and gene therapies
-
Cryoport Announces Pricing of Public Offering of Common Stock at $17.00 per share
6/20/2019
Cryoport, Inc. announced the pricing of its underwritten public offering of an aggregate of 3,750,000 newly issued shares of common stock at a price of $17.00 per share.
-
Cryoport Announces Proposed Public Offering of Common Stock - June 19, 2019
6/19/2019
Cryoport, Inc. announced that it intends to offer shares of common stock in an underwritten public offering under an effective shelf registration statement on file with the Securities and Exchange Commission.
-
Cryoport to Ring the Nasdaq Closing Bell on Monday, June 10 and Attend Jefferies 2019 Healthcare Conference June 4ᵗʰ-7ᵗʰ, 2019
6/5/2019
Cryoport, Inc. announced its Chief Executive Officer, Jerrell Shelton, and other members of the management team, will ring the Nasdaq closing bell on Monday, June 10, 2019.
-
CalAmp Announces Research Collaboration with Cryoport to Develop Next Generation Condition Monitoring System
5/16/2019
CalAmp SC iOn Command™ supply chain visibility service and Cryoport's suite of logistics solutions for the life sciences combine to develop solutions to protect and preserve shipments of regenerative therapies
-
Cryoport Expands into Biostorage through the Acquisition of Cryogene
5/14/2019
Acquisition is expected to be accretive to earnings and brings new industry-leading clients to Cryoport
-
Cryoport to Host Workshop at 14th Annual World Advanced Therapies & Regenerative Medicine Congress on Wednesday, May 15th
5/9/2019
Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Company"), the world's leading temperature-controlled logistics company dedicated to the life sciences industry, announced today its 2nd annual workshop, titled, 'Process Considerations for Cryogenic and Regenerative Medicine Commercialization,' taking place on Wednesday, May 15, 2019
-
Cryoport Revenue Grows 65% for First Quarter 2019
5/2/2019
Commercial revenue rises to 25% of total biopharma revenue; 383 clinical trials supported
-
Cryoport to Report First Quarter 2019 Financial Results on May 2nd, 2019
4/25/2019
Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport" or "the Company"), the world's leading temperature-controlled logistics company dedicated to the life sciences industry, today announced that the Company will report financial results for the first quarter ended March 31, 2019 on Thursday, May 2, 2019 after U.S. markets close.
-
Celularity Selects Cryoport's Temperature Controlled Logistics Solutions
4/11/2019
Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Company"), the world's leading temperature-controlled logistics company dedicated to the life sciences industry, today announced it has been selected by Celularity, a world leading allogeneic cell therapy company, to utilize its complete range of temperature-controlled solutions.
-
Cryoport Reports 64% Growth for Fiscal Year 2018
3/7/2019
Cryoport now supports 357 clinical trials in the Americas and EMEA with 47 in Phase III
-
Cryoport to Report Fourth Quarter and Fiscal Year 2018 Financial Results on March 7th, 2019
2/26/2019
Cryoport, Inc. announced that the Company will report financial results for the fourth quarter and fiscal year ended December 31, 2018 on Thursday, March 7, 2019 after U.S. markets close.
-
Cryoport Opens Global Logistics Center in Amsterdam
1/30/2019
Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Company"), the world's leading temperature-controlled logistics company dedicated to the life sciences industry, today will celebrate the official opening of its most recent Global Logistics Center, based in Amsterdam, The Netherlands.
-
Dacos A/S Partners with Cryoport to Offer Full Suite of Temperature-Controlled Logistics Solutions to Global Client Base
1/14/2019
Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport" or "the Company"), the world's leading temperature-controlled logistics company dedicated to the life sciences industry, today announced it has partnered with Dacos A/S ("Dacos"), a high-tech production company of life sciences products with headquarters in Denmark,
-
Cryoport Appoints Daniel M. Hancock to Board of Directors
1/7/2019
Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Company"), the world's leading temperature-controlled logistics company dedicated to the life sciences industry, is pleased to announce the appointment of Daniel M. (Dan) Hancock to its Board of Directors.
-
Cryoport Announces $25 Million Investment from Petrichor Healthcare Capital Management
12/17/2018
Petrichor purchased $10 million of Cryoport common shares at a price per share of $10.00.